Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 249 participants.
Also called NCT02586129
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 249 participants
- Sponsor
- Registry
-
NCT02586129
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02586129. Randomized; double masking; primary purpose treatment. Start 2015-11-04 (actual); primary completion 2017-07-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
- Condition
- Dyslipidemia
- Condition
- Type II Diabetes
- Intervention (Drug)
- YH14755
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Rosuvastatin
- Lead sponsor
- Yuhan Corporation
Record details
- Record id
cardio:ct-nct02586129- Content hash
671380d4b370a0c9ac108c094b93e1909816b33be0b189d65c2fc948a7534893